...
首页> 外文期刊>Molecular Genetics & Genomic Medicine >Novel KLHL26 variant associated with a familial case of Ebstein’s anomaly and left ventricular noncompaction
【24h】

Novel KLHL26 variant associated with a familial case of Ebstein’s anomaly and left ventricular noncompaction

机译:与Ebstein异常和左心室不相信的家族情况相关的新型KLHL26变体

获取原文
           

摘要

Background Ebstein's anomaly (EA) is a rare congenital heart disease of the tricuspid valve and right ventricle. Patients with EA often manifest with left ventricular noncompaction (LVNC), a cardiomyopathy. Despite implication of cardiac sarcomere genes in some cases, very little is understood regarding the genetic etiology of EA/LVNC. Our study describes a multigenerational family with at least 10 of 17 members affected by EA/LVNC. Methods We performed echocardiography on all family members and conducted exome sequencing of six individuals. After identifying candidate variants using two different bioinformatic strategies, we confirmed segregation with phenotype using Sanger sequencing. We investigated structural implications of candidate variants using protein prediction models. Results Exome sequencing analysis of four affected and two unaffected members identified a novel, rare, and damaging coding variant in the Kelch‐like family member 26 (KLHL26) gene located on chromosome 19 at position 237 of the protein (GRCh37). This variant region was confirmed by Sanger sequencing in the remaining family members. KLHL26 (c.709C??T p.R237C) segregates only with EA/LVNC‐affected individuals (FBAT p??.05). Investigating structural implications of the candidate variant using protein prediction models suggested that the KLHL26 variant disrupts electrostatic interactions when binding to part of the ubiquitin proteasome, specifically Cullin3 (CUL3), a component of E3 ubiquitin ligase. Conclusion In this familial case of EA/LVNC, we have identified a candidate gene variant, KLHL26 (p.R237C), which may have an important role in ubiquitin‐mediated protein degradation during cardiac development.
机译:背景Ebstein的异常(EA)是三尖瓣瓣膜和右心室的罕见先天性心脏病。 ea患者常用于左心室不符号(Lvnc),心肌病。尽管在某些情况下,尽管存在心脏肉瘤基因,但关于EA / LVNC的遗传病程很少。我们的研究描述了一种多蛋白家族,其中至少10个受EA / LVNC影响的17个成员。方法我们对所有家庭成员进行了超声心动图,并进行了六个人的exome序列。在使用两种不同的生物信息策略识别候选变体之后,我们使用Sanger测序确认了表型的偏析。我们使用蛋白质预测模型调查了候选变体的结构性影响。结果四个受影响和两个未受影响的成员的外序分析鉴定了位于蛋白质(GRCH37)的染色体237上的KELCH样家26(KLH126)基因中的新型,罕见和损伤的编码变体。通过剩余的家庭成员中的Sanger测序确认该变体区域。 KLHL26(C.709C?>?T P.R237C)仅与受EA / LVNC受影响的个体间隔(FBAT P?<β.05)。研究使用蛋白质预测模型研究候选变体的结构意义,表明KLHL26变体在与遍突蛋白蛋白酶体的一部分结合时破坏静电相互作用,特别是Cullin3(Cul3),E3泛素连接酶的组分。结论在EA / LVNC的这个家族情况下,我们已经确定了候选基因变体KLHL26(P.R237C),其在心脏发育过程中遍布泛素介导的蛋白质降解中可能具有重要作用。
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号